Dianosic has been selected by Challenges magazine as one of the 100 innovative startups where it is worth to invest in 2021 ! Learn more : “Dianosic : innovations disruptives pour les affections ORL”
Share this article
Challenges – Dianosic has been selected among the 100 most innovative startups to invest in 2021
Discover our other articles
We are pleased to announce the closing of a €7 million financing round. This milestone marks a major step forward for Dianosic and further…
Dianosic launches a WiSEED backed convertible bonds transaction to accelerate innovation in the treatment of chronic allergic rhinitis. This initiative aims to support the…
Dec 15, 2025
Dianosic shortlisted for the “Trophées des Entreprises Alsace 2024” award
Awards
We are delighted to announce that Dianosic is one of the nominees for the 2024 edition of the “Trophées des entreprises d’Alsace”. This selection…
